Alamgir KHAN, Manohar KACHARE, Nagesh MANE

5857

Covid-19 Reinfection Dynamics-Is Immunity Short Lasting? Case Series of Healthcare Workers

The rapidly spreading Covid-19 pandemic resulted in more than 4.7 million cases diagnosed and 78,727 deaths on September 14, 2020. SARS-CoV-2 was first expected to induce a monophasic disease with at least transient immunity. Here we report a case series of five cases of RT-PCR proved reinfection of Covid-19 in health care workers. On returning to work they might experience a Covid-19 “recurrence” or “reactivation” with increased severity of symptoms after a median symptom-free interval requiring hospitalization which raises the question is the immunity short-lasting. Further studies are required to fully understand the effect of Covid-19 on the immunity of humans in the community. J Microbiol Infect Dis 2021; 11(2):105-107.
Keywords:

Covid-19, Severe acute respiratory syndrome coronavirus 2 Pandemic, Recurrence, Coronavirus infection,

PDF

___

  • 1. Kiyuka PK, Agoti CN, Munywoki PK, et al. Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya. J Infect Dis. 2018; 217(11):1728-1739.
  • 2. Tang F, Quan Y, Xin ZT, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011; 186(12):7264-7268.
  • 3. Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect 2020 80(5):e14-e17.
  • 4. Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 2020;181(7):1489-1501.e15.
  • 5. Xiao AT, Tong YX, Zhang S. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients. Clin Infect Dis 2020; 19;71(16):2249-2251.
  • 6. Gousseff M, Penot P, Gallay L, et al. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect 2020; 81(5):816-846.
  • 7. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034.
  • 8. Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020; 133(9):1039-1043.
Journal of Microbiology and Infectious Diseases-Cover
  • ISSN: 2146-3158
  • Başlangıç: 2011
  • Yayıncı: Sağlık Araştırmaları Derneği
Arşiv
Sayıdaki Diğer Makaleler

Abbas Ali HUSSEİNİ, Emel ÇAKAR, Mehran ROSTAMZADE, Musa JOYA, Reza KHAKİ, Mehrad KHOSRAVİ, Freshta AMİRY, Nerges GHADİRİ, Maryam HOSSEİNİ

Ashish WİLLİAM, Yogita RAI, Ravinder KAUR

Alamgir KHAN, Manohar KACHARE, Nagesh MANE

Aishat Temitope ALONGE, Babatunde Isaac ADEMUSİRE, Chinweoge Frances EPUM, Boluwatife Adeleye ADEWALE, Opeoluwa Samuel ADEFARATİ

Divya SUKUMARAN, Mohamed HATHA

Christina AVİLA, Stephanie TROVAT, Catherine CHUNG, Benjamin KAFFENBERGER

Nargis Alom CHOUDHURY, Deepjyoti PAUL, Bhaskar Jyoti DAS, Debadatta Dhar CHANDA, Amitabha BHATTACHARJEE

Amresh Kumar SİNGH, Ankur KUMAR, Vivek GAUR, Indra Prasad ADHİKARİ, Raj Kishore SİNGH

Omer Hassan Siddig ELAMİN, Mai Abdalla ALI, Ibrahim Alhag Almahadi ELGEZULİ, Mona Alrasheed BASHİR, Ivan KAHWA

Faith Feranmi FOLAHAN, Luke Ekundayo EDUNGBOLA, Joy Temiloluwa FOLAHAN